Back to results
CompletedPhase 2

PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease

NCT04052737

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Post Graduate Institute of Medical Education and Research

Chandigarh, India

+4 additional locations

View on ClinicalTrials.gov
PMZ-1620 (Sovateltide) in Mild to Moderate Alzheimer's Disease — TrialFind